View Author
Brook, R.H.
( R.H. Brook)
decision treatment patient mm cells disease ptdin cancer ship 1 inhibitor ptca decisions opm 2 cells artery artery disease inhibition ship 2 3 ac treatment type c lesions lesion figure appropriateness centre study apoptosi panel 1 pie tumor ducat 6 ptq concentration mm cell lines phosphatase result cabg decisions netherland protein 2 piq breast heart pan-ship percutaneous transluminal angioplasty cell viability ducat panel ship 2 inhibition intention number revascularisation growth pan-ship inhibitors expression activation caspase viability indication survival analysis heart centres rpmi 8226 cells presence type c lesion ship 1 inhibition fuhler cycle effect inositol antibody health activity university compound clinician ship 2 expression infarction breast cancer cells blood score death data collectors assay angina
2 Most Recent Publications
|
Therapeutic potential of SH2 domain-containing inositol-5′-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer
(Article)
Fuhler, G.M. Brook, R.H. Tom, B. Iyer, S. Gengo, E.A. Park, M.Y. Gumbleton, M. Viernes, D.R. Chisholm, J.D. Kerr, W.G. |
2012-01-01
|
|
The appropriateness of intention to treat decisions for invasive therapy in coronary artery disease in The Netherlands
(Article)
Meijler, A.P. Rigter, H.G.M. Bernstein, S.J. Scholma, J.K. McDonnell, J. Breeman, A. Kosecoff, J.B. Brook, R.H. |
1997-01-01
|
